ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,837Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 298

$378K Total Retail Price of All Prescriptions

Rank: 66 out of 298

415 Patients Receiving at Least One Drug in Part D
82% Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in South Dakota
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 415 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 415 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
SIMVASTATIN 287 234 43 1 3
LEVOTHYROXINE SODIUM 265 242 53 2 1
OMEPRAZOLE 242 193 45 3 2
LISINOPRIL 219 187 35 4 4
HYDROCODONE-ACETAMINOPHEN 216 145 46 S3 5 8
HYDROCHLOROTHIAZIDE 215 197 43 6 14
AMLODIPINE BESYLATE 212 190 34 7 6
METOPROLOL TARTRATE 181 176* 23 8 10
ENALAPRIL MALEATE 169 164* 31 9 70
POTASSIUM CHLORIDE 151 127 20 10 12
TAMSULOSIN HCL 124 99 20 11 21
GLIMEPIRIDE 113 108* 20 12 65
METFORMIN HCL 108 103* 22 13 11
FUROSEMIDE 106 94 21 14 5
CITALOPRAM HBR 104 78 16 15 19
LOSARTAN POTASSIUM 95 90* 20 16 15
SERTRALINE HCL 95 90* 15 16 20
SYNTHROID 94 76 15 18 49
TRAMADOL HCL 91 75 25 19 16
AMITRIPTYLINE HCL 89 69 16 R 20 63
MELOXICAM 87 82* 24 21 39
ADVAIR DISKUS 86 63 14 22 44
METOPROLOL SUCCINATE 76 71* 17 23 13
WARFARIN SODIUM 73 <11 <11 24 7
GABAPENTIN 73 30 17 24 18
VENLAFAXINE HCL ER 72 <11 <11 26 88
CARVEDILOL 71 71 11 27 24
ZOLPIDEM TARTRATE 69 53 18 28 31
ALLOPURINOL 69 69 16 28 27
FLUTICASONE PROPIONATE 68 63* 19 30 37
BUMETANIDE 66 <11 <11 31 81
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 <11 <11 32 33
LOSARTAN-HYDROCHLOROTHIAZIDE 62 62 12 33 46
TRAZODONE HCL 61 28 12 34 36
DONEPEZIL HCL 61 <11 <11 34 23
SPIRIVA 59 54* 11 36 50
LANTUS 58 <11 <11 37 73
ATENOLOL 58 <11 <11 37 17
ALPRAZOLAM 57 <11 <11 B 39 40
PAROXETINE HCL 56 <11 <11 40 53
DILTIAZEM 24HR CD 55 55 12 41 87
DIOVAN 54 <11 <11 42 52
CRESTOR 54 <11 <11 42 25
LORAZEPAM 53 35 13 B 44 30
CIPROFLOXACIN HCL 53 48* 39 44 68
PIOGLITAZONE HCL 51 <11 <11 R 46 86
METFORMIN HCL ER 51 <11 <11 46 55
NAMENDA 50 <11 <11 48 29
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.